U.S. Biotech Stock News

Why General Mills is on investors’ radar today General Mills (GIS) has drawn attention after a period of weaker share performance, with the stock showing negative returns over the past month and past 3 months, prompting closer scrutiny of its current valuation and fundamentals. See our latest analysis for General Mills. The share price has been under steady pressure, with a 30 day share price return of 18.41% and a 1 year total shareholder return of 33.73%, suggesting momentum has been fading...

Q4 earnings, AI advertising progress, and a new dividend draw focus to Weibo Weibo (WB) is back in focus after its latest quarterly results, which combined modest topline growth with a Q4 net loss, softer non GAAP earnings, and a fresh annual cash dividend declaration. See our latest analysis for Weibo. Despite the AI advertising push and fresh dividend, momentum in the shares has been weak, with a 7 day share price return of 11.18% and a 1 year total shareholder return of a 4.72% loss,...

What recent performance says about Himax Technologies (HIMX) Himax Technologies (HIMX) has drawn fresh attention after a mixed stretch in the market, with a 4.4% one day decline and a 12.7% pullback over the past week, in contrast with positive returns over the past month and past three months. See our latest analysis for Himax Technologies. That recent weak share price momentum sits alongside a 14.7% 1 month share price return and a 5.6% 1 year total shareholder return. This suggests...

Recent price performance and business backdrop Centuri Holdings (CTRI) has seen mixed share performance recently, with a 4.2% decline over the past day, a small slip over the past week, and a larger pullback over the past month. Those short term moves sit against an 11.4% gain over the past 3 months, a 12.8% return year to date, and an 83.9% total return over the past year, putting the current US$29.12 share price in context. Behind the stock, Centuri operates a utility infrastructure...

Investors may be wondering whether Berkshire Hathaway at around US$480.94 is a bargain or fully priced, particularly after such a long period as a market bellwether. The stock has slipped 1.9% over the last week, 3.6% over the last month, 3.2% year to date, and 7.8% over the last year, while the 3 year and 5 year returns stand at 60.9% and 87.3% respectively. These recent moves come as investors continue to weigh Berkshire Hathaway's broad mix of operating businesses and its large equity...

On 18 March 2026, Samsung Electronics announced a memorandum of understanding with AMD to expand their collaboration on next-generation AI memory and computing, centering on primary HBM4 supply for the Instinct MI455X GPU, advanced DDR5 for 6th Gen EPYC “Venice” CPUs, and exploring future foundry manufacturing. This deepened tie-up suggests AMD is working to secure critical high-bandwidth memory and potential manufacturing capacity, a key consideration for scaling its AI accelerator and data...

If you are looking at HCA Healthcare and wondering whether the current share price still offers value, the recent numbers give you quite a bit to think about. The stock closed at US$493.88, with returns of 5.0% year to date and 51.2% over 1 year, while the last 7 and 30 days showed pullbacks of 7.3% and 7.7%. Recent coverage around HCA Healthcare has focused on its scale as a major hospital operator and its role in the broader US healthcare system. This often shapes how investors think about...

If you are wondering whether SM Energy at around US$30.04 offers value or is just noise in a volatile sector, this breakdown will help you size up the stock with a clear valuation lens. The share price shows sharp recent moves, with returns of 12.1% over 7 days, 28.4% over 30 days, 57.0% year to date and 2.4% over the past year. These shifts can change how the market is pricing in both growth potential and risk. Recent coverage has focused on SM Energy's position within the US energy space...

DICK'S Sporting Goods (DKS) stock is back in focus after fourth quarter earnings topped revenue and adjusted profit expectations, accompanied by upbeat 2026 guidance and a 3% quarterly dividend increase. See our latest analysis for DICK'S Sporting Goods. Despite the upbeat earnings surprise, guidance and dividend increase, the recent share price has softened, with a 30 day share price return of 6.31% and a 90 day share price return of 10.43%. In contrast, the 3 year total shareholder return...

In March 2026, NextEra Energy, Inc. confirmed that President Donald J. Trump had approved development of up to 10 gigawatts of natural gas-powered generation in Texas and Pennsylvania, tied to Japan's US$550 billion U.S. investment commitment under the recent U.S.-Japan trade deal. The projects, which would be jointly owned by Japan and the U.S. and built and operated by NextEra Energy, highlight the company’s growing role in large-scale gas infrastructure alongside its established...

StandardAero (SARO) has agreed to provide maintenance, repair, and overhaul services for Robinson Helicopter Company’s global R66 fleet powered by Rolls Royce RR300 engines, giving R66 operators a manufacturer recommended MRO partner. See our latest analysis for StandardAero. The new Robinson Helicopter agreement comes as StandardAero’s share price, now at US$25.60, has recorded a 30 day share price return of 18.11% decline and a year to date share price return of 13.63% decline, with a 1...

In March 2026, Jefferies upgraded The Simply Good Foods Company after arguing that the market was underappreciating the strength of its Quest brand and its heavy exposure to protein-focused snacks like bars, shakes and salty snacks. At the same time, recent congressional share purchases and growing attention on high‑protein, low‑carb eating patterns have reinforced Simply Good Foods’ positioning within what some investors see as a broader “protein megatrend.” We’ll now examine how Jefferies’...

Earlier this week, OPENLANE, Inc. reported US$494.3 million in revenue for the latest period, an 8.6% year-on-year increase that exceeded analyst expectations by 4.4%, while also presenting at the Bank of America Global Automotive Summit with CEO Peter J. Kelly and CFO Bradley Herring. Despite the revenue beat, the company’s shortfall versus analysts’ full-year EPS guidance and estimates highlighted ongoing profitability pressures even as management pointed to strong execution and strategic...

If you are trying to work out whether NVR at around US$6,369.38 is a bargain or a value trap, it helps to start with the recent share price path and what the current valuation signals are really saying. The stock has seen a 1.5% decline over the last week, a 15.3% decline over the past month, and is down 12.5% year to date, while the 1 year return sits at an 11.3% decline and the 3 and 5 year returns are 17.7% and 34.9% respectively. Recent coverage has focused on how NVR's share price...

How Range Resources stock has been performing Range Resources (RRC) has seen mixed short term moves, with a 1.8% decline over the past day and a 2.2% gain over the past week, while the share price remains around US$44.47. Looking a bit further out, the stock shows an 18.5% return over the past month and 28.9% over the past 3 months, set against a market value of about US$10.7b. See our latest analysis for Range Resources. RRC’s recent momentum is strong, with a 30 day share price return of...

Event driven spotlight on Insmed stock Recent commentary from Artisan Partners put Insmed (INSM) back in focus after its exit from the Artisan Small Cap Fund, citing market cap constraints rather than concerns about the business. The letter highlighted the launch of Brinsupri, or brensocatib, as the first approved therapy for non cystic fibrosis bronchiectasis. It noted initial sales of US$28 million and support from a broad rare disease pipeline that some investors are watching closely. See...

Photronics (PLAB) is back in focus after reporting quarterly revenue growth of 6.1% year on year. The company topped analyst expectations on both sales and earnings while updating investors on facility expansion and geographic diversification plans. See our latest analysis for Photronics. The share price reaction has been mixed, with a 9.8% 90 day share price return and an 8.3% gain over the past week, while the 1 year total shareholder return of 73.0% signals strong longer term momentum. If...

If you are wondering whether Antero Resources at around US$43.09 is offering fair value or not, it helps to step back and look at what the recent share performance is actually telling you. The stock has returned 5.1% over the last week, 27.3% over the last month and 26.0% year to date, while the 1 year return sits at 5.7% and the 3 year return is 98.4%. Recent coverage has focused on Antero Resources within broader discussions of US energy producers and investor interest in gas focused...

Why Catalyst Pharmaceuticals Stock Is On Investors’ Radar Catalyst Pharmaceuticals (CPRX) is drawing attention after recent trading data showed mixed returns, with the share price at $22.79 and total returns varying across the past week, month and past 3 months. See our latest analysis for Catalyst Pharmaceuticals. The 1 day share price return of 2.06% comes after a softer patch, with the 30 day share price return of 6.18% and year to date share price return of 1.56% pointing to momentum that...

Recent share performance snapshot Twilio (TWLO) has seen mixed share performance lately, with a 2.5% decline over the past day and a broadly flat move over the week, alongside a 12.2% gain over the past month. See our latest analysis for Twilio. Zooming out, Twilio’s recent pullback sits against a mixed picture, with a 12.2% 1 month share price return, a 10.3% year to date share price decline, and a 19.97% 1 year total shareholder return. This suggests short term momentum after a tougher...

On March 16, 2026, American International Group, Inc. and McGill and Partners announced a collaboration to use agentic AI and real-time data to underwrite up to US$1.60 billion of specialty Gross Premiums Written via McGill and Partners’ digital broking platform. By integrating Palantir’s Foundry with McGill and Partners’ tech-enabled data and AIG’s underwriting criteria, the partners aim to manage insurance capacity in near real time, potentially reshaping how specialty risk portfolios are...

Event-driven snapshot of BlackLine BlackLine (BL) has come into focus after a period where the share price shows mixed recent returns, with a gain over the past month but a decline across the past 3 months and year to date. See our latest analysis for BlackLine. Recent trading tells a mixed story, with a 6.1% 7 day share price return and a 5.3% 30 day share price return set against a 32.4% 90 day share price decline and a 64.0% 5 year total shareholder return loss. This suggests momentum has...

Why Rithm Capital is back on investors’ radar Rithm Capital (RITM) is drawing fresh attention after reporting Q4 2025 non GAAP earnings available for distribution of $0.74 per share, beating consensus by 29%, alongside 18.4% year over year revenue growth. See our latest analysis for Rithm Capital. Despite the strong Q4 report and the ongoing shift toward an asset management model, the share price has retreated. The 30 day share price return is 17.4% and the 1 year total shareholder return is...

Wondering if Lowe's Companies at around US$224 per share still offers value, or if most of the opportunity is already priced in. The stock is roughly flat over 1 year with a 0.9% return, but that sits alongside a 5.5% decline over the last 7 days and a 20.4% decline over the last 30 days, leaving the year to date return at a 9.0% decline. These recent moves come as investors continue to reassess large U.S. retailers and home improvement names in light of shifting consumer demand and...